{
  "id": 8332902,
  "title": "Anthropic is operating a lab that conducts biology experiments",
  "url": "https://urgent.news/2026/09/18/anthropic-is-operating-a-lab-that-conducts-biology-experiments",
  "topic": "ai",
  "section": "AI",
  "published": "2026-09-18T23:13:31.000Z",
  "source": {
    "name": "TechCrunch",
    "slug": "techcrunch",
    "url": "https://techcrunch.com/2026/09/18/anthropic-is-operating-a-lab-that-conducts-biology-experiments/"
  },
  "original_language": "en",
  "account": "Anthropic, a leading AI company, has confirmed the existence of a wet biology lab in the Bay Area where it can utilize its AI models to conduct physical experiments. This revelation comes after AI leaders, including Dario Amodei, expressed optimism that AI could potentially cure most major diseases within the next 5-10 years. Amodei, Anthropic's head of life sciences, stated that the final test for AI in biology still involves real lab work. Anthropic's wet lab, which operates similarly to other biotech labs, focuses on fundamental biology rather than drug discovery. The company recently acquired Coefficient Bio, an AI biotech startup, in April. While specific details about the lab's current projects are not disclosed, Anthropic emphasizes its commitment to avoiding the appearance of competing with pharma industry giants. The company has also implemented measures such as a Life Sciences Verification Program and published reports on its drug discovery research to reassure stakeholders. However, the tech industry remains divided over Anthropic's decision to establish the wet lab, with some viewing it as a bold move to bridge the gap between AI and real-world biological experimentation.",
  "summary": "AI leaders have been promising that AI is the key to curing human disease. Anthropic researchers have also been warning that AI might kill us all.",
  "key_points": [
    "Anthropic operates a wet biology lab in Bay Area.",
    "Head of life sciences Dario Amodei sees AI curing major diseases in 5-10 years.",
    "Company acquired AI biotech startup Coefficient Bio in April."
  ],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}